CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -11.4% | 14,530 | +42.3% | 0.00% | – |
| Q4 2021 | $44,000 | -72.0% | 10,209 | -66.9% | 0.00% | -100.0% |
| Q3 2021 | $157,000 | +115.1% | 30,846 | +166.5% | 0.00% | – |
| Q2 2021 | $73,000 | -29.8% | 11,574 | -14.1% | 0.00% | -100.0% |
| Q1 2021 | $104,000 | -28.3% | 13,476 | -38.2% | 0.00% | 0.0% |
| Q3 2020 | $145,000 | +43.6% | 21,797 | +80.2% | 0.00% | 0.0% |
| Q2 2020 | $101,000 | -24.1% | 12,098 | -30.3% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | +11.8% | 17,355 | +233.8% | 0.00% | 0.0% |
| Q2 2018 | $119,000 | +1.7% | 5,200 | -30.5% | 0.00% | 0.0% |
| Q3 2016 | $117,000 | – | 7,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |